KBC Group NV Grows Stake in Humana Inc. (NYSE:HUM)

KBC Group NV grew its stake in Humana Inc. (NYSE:HUM - Free Report) by 26.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 48,685 shares of the insurance provider's stock after buying an additional 10,039 shares during the period. KBC Group NV's holdings in Humana were worth $12,352,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. Atlas Brown Inc. raised its holdings in shares of Humana by 0.6% in the 4th quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider's stock worth $1,611,000 after purchasing an additional 38 shares during the period. Moors & Cabot Inc. increased its position in Humana by 2.5% in the third quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider's stock worth $519,000 after buying an additional 40 shares during the last quarter. OLD National Bancorp IN raised its stake in shares of Humana by 1.8% in the third quarter. OLD National Bancorp IN now owns 2,613 shares of the insurance provider's stock valued at $828,000 after buying an additional 45 shares during the period. Your Advocates Ltd. LLP grew its stake in shares of Humana by 81.8% during the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider's stock worth $32,000 after acquiring an additional 45 shares during the period. Finally, Brooklyn Investment Group increased its holdings in Humana by 6.7% in the 3rd quarter. Brooklyn Investment Group now owns 736 shares of the insurance provider's stock worth $233,000 after acquiring an additional 46 shares during the last quarter. Institutional investors own 92.38% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have commented on HUM shares. Leerink Partnrs downgraded shares of Humana from a "strong-buy" rating to a "hold" rating in a report on Wednesday, October 2nd. TD Cowen upped their price target on shares of Humana from $261.00 to $268.00 and gave the company a "hold" rating in a research note on Monday, November 4th. Wells Fargo & Company reduced their price objective on shares of Humana from $387.00 to $290.00 and set an "overweight" rating for the company in a research note on Monday, November 4th. Leerink Partners lowered Humana from an "outperform" rating to a "market perform" rating and cut their price target for the stock from $400.00 to $250.00 in a report on Wednesday, October 2nd. Finally, Stephens reiterated an "equal weight" rating and set a $250.00 price objective on shares of Humana in a research note on Wednesday, October 9th. Nineteen equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, Humana currently has an average rating of "Hold" and a consensus price target of $297.68.

Humana Trading Up 0.3 %

Shares of HUM traded up $0.86 during mid-day trading on Thursday, reaching $295.09. The company's stock had a trading volume of 654,819 shares, compared to its average volume of 1,505,360. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $406.46. The company's fifty day moving average price is $275.44 and its two-hundred day moving average price is $303.07. The stock has a market cap of $35.53 billion, a PE ratio of 26.18, a P/E/G ratio of 2.15 and a beta of 0.55.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.48 by $0.68. The business had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. On average, analysts predict that Humana Inc. will post 16.11 earnings per share for the current fiscal year.

Insider Transactions at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the sale, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 0.32% of the company's stock.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.